Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant FAC vs FAC-Paclitaxel in Node-Negative Breast Cancer
NCT00129389Phase 3Completed
- Sponsor
- GEICAM
- Start
- Sep 2003
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel in breast cancer, sponsored by GEICAM. Started Sep 2003; status: completed.
02
Drugs
paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00129389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00129389.